{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:31:08Z","timestamp":1791351068617,"version":"4.3.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"7580","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1038\/nature16046","type":"journal-article","created":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T17:21:49Z","timestamp":1449163309000},"page":"S68-S76","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":150,"title":["Sustainable HIV treatment in Africa through viral-load-informed differentiated care"],"prefix":"10.1038","volume":"528","author":[{"given":"Andrew","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Shroufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Vojnov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Ellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"Garnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Cambiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiyo","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loveleen","family":"Bansi-Matharu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec","family":"Miners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens D.","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W.","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind","family":"Parkes-Ratanshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Maman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Vitoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dowdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurine","family":"Murtagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Wareham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara M.","family":"Palamountain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Chakanyuka Musanhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Katzenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ciaranello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruanne","family":"Barnabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Scott","family":"Braithwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Bendavid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusum J.","family":"Nathoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"van de Vijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bershteyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Raizes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilesh","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Peeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fern","family":"Terris-Prestholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Murungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsitsi","family":"Mutasa-Apollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy B.","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Revill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,2]]},"reference":[{"key":"BFnature16046_CR1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2471\/BLT.13.127639","volume":"92","author":"M Siapka","year":"2014","unstructured":"Siapka, M., Remme, M., Dayo Obure, C., Maier, C., Dehne, K. L. & Vassall A. Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries. Bull. World Health Organ. 92, 499\u2013511 (2014).","journal-title":"Bull. World Health Organ."},{"key":"BFnature16046_CR2","doi-asserted-by":"publisher","first-page":"e108304","DOI":"10.1371\/journal.pone.0108304","volume":"9","author":"E Tagar","year":"2014","unstructured":"Tagar, E. et al. Multi-country analysis of treatment costs for HIV\/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia. PLoS ONE 9, e108304 (2014).","journal-title":"PLoS ONE"},{"key":"BFnature16046_CR3","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1097\/QAD.0b013e3283463eec","volume":"25","author":"NA Menzies","year":"2011","unstructured":"Menzies, N. A. et al. The cost of providing comprehensive HIV treatment in PEPFAR-supported programs. AIDS 25, 1753\u20131760 (2011).","journal-title":"AIDS"},{"key":"BFnature16046_CR4","doi-asserted-by":"publisher","first-page":"e1001369","DOI":"10.1371\/journal.pmed.1001369","volume":"10","author":"NC Ware","year":"2013","unstructured":"Ware, N. C. et al. Toward an understanding of disengagement from HIV treatment and care in sub-Saharan Africa: a qualitative study. PLoS Med. 10, e1001369 (2013).","journal-title":"PLoS Med."},{"key":"BFnature16046_CR5","unstructured":"World Health Organisation. Technical and Operational Considerations for Implementing HIV Viral Load Testing. Access to HIV diagnostics (WHO, 2014)."},{"key":"BFnature16046_CR6","unstructured":"UNAIDS. Landmark HIV Diagnostic Access Program will Save $150m and Help Achieve New Global Goals on HIV \n                    http:\/\/www.unaids.org\/en\/resources\/presscentre\/pressreleaseandstatementarchive\/2014\/september\/20140925prviralload\n                    \n                   (UNAIDS, 2014)"},{"key":"BFnature16046_CR7","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S0140-6736(08)60624-8","volume":"371","author":"AN Phillips","year":"2008","unstructured":"Phillips, A. N., Pillay, D., Miners, A. H., Bennett, D. E, Gilks, C. F. & Lundgren, J. D. Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model. Lancet 371, 1443\u20131451 (2008).","journal-title":"Lancet"},{"key":"BFnature16046_CR8","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1097\/QAD.0b013e3283536988","volume":"26","author":"J Estill","year":"2012","unstructured":"Estill, J. et al. Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis. AIDS 26, 1403\u20131413 (2012).","journal-title":"AIDS"},{"key":"BFnature16046_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1758-2652-14-38","volume":"14","author":"RS Braithwaite","year":"2011","unstructured":"Braithwaite, R.S. et al. Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives? J. Intl AIDS Soc. 14, 38 (2011).","journal-title":"J. Intl AIDS Soc."},{"key":"BFnature16046_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/QAI.0b013e3181d0db97","volume":"54","author":"AD Kimmel","year":"2010","unstructured":"Kimmel, A.D. et al. Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness. J. Acquir. Immune Defic. Syndr. 54, 258\u2013268 (2010).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"BFnature16046_CR11","doi-asserted-by":"crossref","unstructured":"Braithwaite, R. S. et al. How do different eligibility guidelines for antiretroviral therapy affect the cost-effectiveness of routine viral load testing in sub-Saharan Africa? AIDS 28 (Suppl 1), S73\u2013S83 (2013).","DOI":"10.1097\/QAD.0000000000000110"},{"key":"BFnature16046_CR12","doi-asserted-by":"publisher","first-page":"e57611.15","DOI":"10.1371\/journal.pone.0057611","volume":"8","author":"J Estill","year":"2013","unstructured":"Estill, J. et al. Monitoring of antiretroviral therapy programmes in Malawi, South Africa and Zambia: Mathematical Modelling Study. PLoS ONE 8, e57611.15 (2013).","journal-title":"PLoS ONE"},{"key":"BFnature16046_CR13","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/S2214-109X(13)70048-2","volume":"2","author":"D Keebler","year":"2013","unstructured":"Keebler, D. et al. Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models. Lancet Glob. Health 2, e35\u2013e43 (2013).","journal-title":"Lancet Glob. Health"},{"key":"BFnature16046_CR14","first-page":"168","volume":"17","author":"E Bendavid","year":"2008","unstructured":"Bendavid, E. et al. Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis. Arch. Int. Med. 17, 168 (2008).","journal-title":"Arch. Int. Med."},{"key":"BFnature16046_CR15","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1097\/QAD.0b013e3283560678","volume":"26","author":"RL Hamers","year":"2012","unstructured":"Hamers, R. L., Sawyer, A. W., Tuohy, M., Stevens, W.S., Rinke de Wit, T. F & Hill, A. M. Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis. AIDS 26, 1663\u20131672 (2012).","journal-title":"AIDS"},{"key":"BFnature16046_CR16","doi-asserted-by":"publisher","first-page":"e0124748","DOI":"10.1371\/journal.pone.0124748","volume":"10","author":"SE Rutstein","year":"2015","unstructured":"Rutstein, S. E. et al. Dried blood spots for viral load monitoring in Malawi: feasible and effective. PLoS ONE 10, e0124748 (2015).","journal-title":"PLoS ONE"},{"key":"BFnature16046_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jcv.2009.11.006","volume":"47","author":"M Andreotti","year":"2010","unstructured":"Andreotti, M. et al. Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche COBAS Taqman assay. J. Clin. Virol. 47, 4\u20137 (2010).","journal-title":"J. Clin. Virol."},{"key":"BFnature16046_CR18","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1128\/JCM.02099-08","volume":"47","author":"C Garrido","year":"2009","unstructured":"Garrido, C. et al. Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests. J. Clin. Microbiol. 47, 1031\u20131036 (2009).","journal-title":"J. Clin. Microbiol."},{"key":"BFnature16046_CR19","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1086\/605502","volume":"49","author":"A Johannessen","year":"2009","unstructured":"Johannessen, A. et al. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania. Clin. Infect. Dis. 49, 976\u2013981 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"BFnature16046_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1469-0691.2008.02116.x","volume":"15","author":"A Marconi","year":"2009","unstructured":"Marconi, A. et al. Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens. Clin. Microbiol. Infect. 15, 93\u201397 (2009).","journal-title":"Clin. Microbiol. Infect."},{"key":"BFnature16046_CR21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1128\/JCM.00418-11","volume":"50","author":"M Arredondo","year":"2011","unstructured":"Arredondo, M. et al. Comparison of HIV-1 RNA measurements using plasma and dried blood spots (DBS) in the Automated Abbott Real Time Viral Load Assay. J. Clin. Microbiol. 50, 569\u2013572 (2011).","journal-title":"J. Clin. Microbiol."},{"key":"BFnature16046_CR22","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1093\/jac\/dkr383","volume":"66","author":"P Pirillo MF-Pinson","year":"2011","unstructured":"Pirillo MF-Pinson, P. et al. Quantification of HIV-RNA from dried blood spots using Siemens VERSANT\u00ae HIV-1 RNA (kPCR) assay. J. Antimicrob. Chemother. 66, 2823\u20132826 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFnature16046_CR23","doi-asserted-by":"publisher","first-page":"102598","DOI":"10.1155\/2014\/102598","volume":"2014","author":"P Ondoa","year":"2014","unstructured":"Ondoa, P. et al. Performance and logistical challenges of alternative HIV-1 virological monitoring options in a clinical setting of Harare, Zimbabwe. BioMed Res. Int. 2014, 102598 (2014).","journal-title":"BioMed Res. Int."},{"key":"BFnature16046_CR24","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1128\/JCM.03519-13","volume":"52","author":"E Fajardo","year":"2014","unstructured":"Fajardo, E. et al. Prospective evaluation of diagnostic accuracy of dried blood spots from finger prick samples for determination of HIV-1 Load with the NucliSENS Easy-Q HIV-1 version 2.0 Assay in Malawi. J. Clinical Microbiol. 52, 1343\u20131351 (2014).","journal-title":"J. Clinical Microbiol."},{"key":"BFnature16046_CR25","doi-asserted-by":"publisher","first-page":"e86461","DOI":"10.1371\/journal.pone.0086461","volume":"9","author":"PW Smit","year":"2014","unstructured":"Smit, P. W. et al. Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis. PLoS ONE 9, e86461 (2014).","journal-title":"PLoS ONE"},{"key":"BFnature16046_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jcv.2014.05.005","volume":"60","author":"E Rutstein","year":"2014","unstructured":"Rutstein, E. et al. Measures of viral load using Abbott RealTime HIV-1 Assay on venousand fingerstick dried blood spots from provider-collected specimens in Malawian District Hospitals. J. Clin. Virol. 60, 392\u2013398 (2014).","journal-title":"J. Clin. Virol."},{"key":"BFnature16046_CR27","doi-asserted-by":"publisher","first-page":"e0126878","DOI":"10.1371\/journal.pone.0126878","volume":"10","author":"SN Mavedzenge","year":"2015","unstructured":"Mavedzenge, S. N. et al. Finger prick dried blood spots for HIV viral load measurement in field conditions in Zimbabwe. PloS ONE 10, e0126878 (2015).","journal-title":"PloS ONE"},{"key":"BFnature16046_CR28","unstructured":"UNITAID. HIV\/AIDS Diagnostics Technology Landscape. Semi Annual Update. \n                    www.unitaid.org\n                    \n                   (UNITAID, 2015)."},{"key":"BFnature16046_CR29","unstructured":"World Bank. Country and Lending Data \n                    http:\/\/data.worldbank.org\/about\/country-and-lending-groups#Sub_Saharan_Africa\n                    \n                   (World Bank, 2015)."},{"key":"BFnature16046_CR30","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/tmi.12460","volume":"20","author":"C Duncombe","year":"2015","unstructured":"Duncombe, C. et al. Reframing HIV care: putting people at the centre of antiretroviral delivery. Trop. Med. Int. Health 20, 430\u2013447 (2015).","journal-title":"Trop. Med. Int. Health"},{"key":"BFnature16046_CR31","doi-asserted-by":"publisher","first-page":"17324","DOI":"10.7448\/IAS.15.2.17324","volume":"15","author":"T Roberts","year":"2012","unstructured":"Roberts, T., Bygrave, H., Fajardo, E. & Ford, N. Challenges and opportunities for the implementation of virological testing in resource-limited settings. J. Int. AIDS Soc. 15, 17324 (2012).","journal-title":"J. Int. AIDS Soc."},{"key":"BFnature16046_CR32","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1093\/infdis\/jit111","volume":"207","author":"V Cambiano","year":"2013","unstructured":"Cambiano, V. et al. Transmission of drug resistant HIV and its potential impact on mortality and treatment outcomes in resource-limited settings. J. Infect. Dis. 207, S57\u2013S62 (2013).","journal-title":"J. Infect. Dis."},{"key":"BFnature16046_CR33","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1097\/QAD.0000000000000082","volume":"28","author":"V Cambiano","year":"2014","unstructured":"Cambiano, V. et al. Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiation. AIDS 28, S15\u2013S23 (2014).","journal-title":"AIDS"},{"key":"BFnature16046_CR34","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/S2352-3018(14)70021-9","volume":"1","author":"AN Phillips","year":"2014","unstructured":"Phillips, A. N. et al. Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis. Lancet HIV 1, e85\u2013e93 (2014).","journal-title":"Lancet HIV"},{"key":"BFnature16046_CR35","doi-asserted-by":"publisher","unstructured":"Cambiano, V. et al. Assessment of the potential impact and cost-effectiveness of self-testing for HIV in low-income countries. J. Infect. Dis. \n                    http:\/\/dx.doi.org\/10.1093\/infdis\/jiv040\n                    \n                   (2015).","DOI":"10.1093\/infdis\/jiv040"},{"key":"BFnature16046_CR36","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/QAD.0b013e328344037a","volume":"25","author":"AN Phillips","year":"2011","unstructured":"Phillips, A. N. et al. Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line regimens in resource-limited settings. AIDS 25, 843\u2013850 (2011).","journal-title":"AIDS"},{"key":"BFnature16046_CR37","doi-asserted-by":"publisher","first-page":"e82724","DOI":"10.1371\/journal.pone.0082724","volume":"8","author":"Y Madec","year":"2013","unstructured":"Madec, Y., Leroy, S., Rey-Cuille, M.-A., Huber. F & Calmy, A. Persistent difficulties in switching to second-line ART in sub-Saharan Africa \u2014 a systematic review and meta-analysis. PLoS ONE 8, e82724 (2013)","journal-title":"PLoS ONE"},{"key":"BFnature16046_CR38","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/QAI.0b013e3182557785","volume":"60","author":"MP Fox","year":"2012","unstructured":"Fox, M. P. et al. Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa. J. Acquir. Immune Defic. Syndr. 60, 428\u2013437 (2012).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"BFnature16046_CR39","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/QAI.0b013e318266ee3f","volume":"1","author":"V Johnston","year":"2012","unstructured":"Johnston, V., Fielding, K. L., Charalambous, S., Churchyard, G., Phillips, A. & Grant, A. D. Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program. J. Acquir. Immune Defic. Syndr. 1, 370\u2013380 (2012).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"BFnature16046_CR40","first-page":"160","volume":"16","author":"N Parkin","year":"2014","unstructured":"Parkin, N. Measurement of HIV-1 viral load for drug resistance surveillance using dried blood spots: literature review and modelling of contribution of DNA and RNA. AIDS Rev. 16, 160\u2013171 (2014).","journal-title":"AIDS Rev."},{"key":"BFnature16046_CR41","volume-title":"Appropriate Perspectives for Health Care Decisions","author":"K Claxton","year":"2010","unstructured":"Claxton, K., Walker, S., Palmer, S. & Sculpher, M. Appropriate Perspectives for Health Care Decisions, Centre for Health Economics Research Paper 54 (Univ. York, 2010)."},{"key":"BFnature16046_CR42","volume-title":"Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research","author":"E Woods","year":"2015","unstructured":"Woods, E., Revill, P., Sculpher, M. & Claxton, K. Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research. \n                    https:\/\/www.york.ac.uk\/media\/che\/documents\/papers\/researchpapers\/CHERP109_cost-effectiveness_threshold_LMICs.pdf\n                    \n                   (Univ. York, 2015)."},{"key":"BFnature16046_CR43","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/S0140-6736(12)61680-8","volume":"380","author":"JA Salomon","year":"2012","unstructured":"Salomon, J. A. et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 380, 2129\u20134310 (2012).","journal-title":"Lancet"},{"key":"BFnature16046_CR44","doi-asserted-by":"publisher","first-page":"e1001725","DOI":"10.1371\/journal.pmed.1001725","volume":"11","author":"EP Hyle","year":"2014","unstructured":"Hyle, E. P. et al. The clinical and economic impact of point-of-care CD4 testing in Mozambique and other resource-limited settings: a cost-effectiveness analysis. PLoS Med. 11, e1001725 (2014).","journal-title":"PLoS Med."},{"key":"BFnature16046_CR45","unstructured":"MSF. Untangling the Web of Antiretroviral Price Reductions \n                    http:\/\/www.msfaccess.org\/content\/untangling-web-antiretroviral-price-reductions\n                    \n                   (MSF, 2014)."},{"key":"BFnature16046_CR46","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/tmi.12278","volume":"19","author":"T Decroo","year":"2014","unstructured":"Decroo, T. et al. Four-year retention and risk factors for attrition among members of community ART groups in Tete, Mozambique. Trop. Med. Int. Health. 19, 514\u2013521 (2014).","journal-title":"Trop. Med. Int. Health."},{"key":"BFnature16046_CR47","doi-asserted-by":"publisher","first-page":"18910","DOI":"10.7448\/IAS.17.1.18910","volume":"17","author":"F Rasschaert","year":"2014","unstructured":"Rasschaert, F. et al. Sustainability of a community-based anti-retroviral care delivery model \u2014 a qualitative research study in Tete, Mozambique. J. Int. AIDS Soc. 17, 18910 (2014).","journal-title":"J. Int. AIDS Soc."},{"key":"BFnature16046_CR48","doi-asserted-by":"crossref","unstructured":"DART Trial Team. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet 375, 123\u2013131 (2010).","DOI":"10.1016\/S0140-6736(09)62067-5"},{"key":"BFnature16046_CR49","unstructured":"MSF. ART Adherence Club Report and Toolkit \n                    http:\/\/www.msf.org\/sites\/msf.org\/files\/cag_toolkit.pdf"},{"key":"BFnature16046_CR50","unstructured":"MSF. Community ART Group Toolkit. How to Implement the CAG Model. Bringing Treatment Closer to Home and Empowering Patients \n                    http:\/\/samumsf.org\/resources\/toolkit-cag\/\n                    \n                   (MSF, 2015)"},{"key":"BFnature16046_CR51","volume-title":"Ways to Reduce Costs and Improve Quality in Patient Monitoring: Barriers to Improvement, Buhera & Gutu District Experience, Zimbabwe. Consultation on Implementation Issues for Monitoring People on ART in Low-Income Settings in Sub-Saharan Africa","author":"S Simons","year":"2015","unstructured":"Simons, S. et al. Ways to Reduce Costs and Improve Quality in Patient Monitoring: Barriers to Improvement, Buhera & Gutu District Experience, Zimbabwe. Consultation on Implementation Issues for Monitoring People on ART in Low-Income Settings in Sub-Saharan Africa (MSF, 2015)."},{"key":"BFnature16046_CR52","doi-asserted-by":"publisher","first-page":"e18193","DOI":"10.1371\/journal.pone.0018193","volume":"6","author":"JB Babigumira","year":"2011","unstructured":"Babigumira, J. B. et al. Cost-effectiveness of a pharmacy-only refill program in a large urban HIV\/AIDS clinic in Uganda. PLoS ONE 6, e18193 (2011).","journal-title":"PLoS ONE"},{"key":"BFnature16046_CR53","unstructured":"UNAIDS and MSF. Community Based ART Delivery (UNAIDS, 2015)."},{"key":"BFnature16046_CR54","doi-asserted-by":"publisher","first-page":"19984","DOI":"10.7448\/IAS.18.1.19984","volume":"18","author":"A Grimsrud","year":"2015","unstructured":"Grimsrud, A. et al. Implementation of community-based adherence clubs for stable antiretroviral therapy patients in Cape Town, South Africa. J. Int. AIDS Soc. 18, 19984 (2015).","journal-title":"J. Int. AIDS Soc."},{"key":"BFnature16046_CR55","unstructured":"MSF and UNAIDS. Closer to Home \n                    http:\/\/www.msfaccess.org\/sites\/default\/files\/MSF_assets\/HIV_AIDS\/Docs\/AIDS_report_ClosertoHome_ENG_2012.pdf\n                    \n                   (MSF, 2012)."},{"key":"BFnature16046_CR56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(04)16589-6","volume":"364","author":"B Ledergerber","year":"2004","unstructured":"Ledergerber, B. et al. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes. Lancet 364, 51\u201362 (2004).","journal-title":"Lancet"},{"key":"BFnature16046_CR57","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1097\/QAD.0000000000000727","volume":"29","author":"F Terris-Prestholt","year":"2015","unstructured":"Terris-Prestholt F. First-line antiretroviral therapy for HIV-infected children. AIDS 29, 1261\u20131262 (2015).","journal-title":"AIDS"},{"key":"BFnature16046_CR58","doi-asserted-by":"publisher","first-page":"d6792","DOI":"10.1136\/bmj.d6792","volume":"343","author":"J Mermin","year":"2011","unstructured":"Mermin, J. et al. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial. Br. Med. J. 343, d6792 (2011).","journal-title":"Br. Med. J."},{"key":"BFnature16046_CR59","doi-asserted-by":"publisher","first-page":"d6884","DOI":"10.1136\/bmj.d6884","volume":"343","author":"JG Kahn","year":"2011","unstructured":"Kahn, J. G. et al. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectivness study. Br. Med. J. 343, d6884 (2011).","journal-title":"Br. Med. J."},{"key":"BFnature16046_CR60","doi-asserted-by":"crossref","unstructured":"DART Trial Team. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet 375, 123\u2013131 (2010).","DOI":"10.1016\/S0140-6736(09)62067-5"},{"key":"BFnature16046_CR61","doi-asserted-by":"publisher","first-page":"e1001494","DOI":"10.1371\/journal.pmed.1001494","volume":"10","author":"G Jourdain","year":"2013","unstructured":"Jourdain, G. et al. Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand. PLoS Med 10, e1001494 (2013).","journal-title":"PLoS Med"},{"key":"BFnature16046_CR62","volume-title":"19th Conf. Retroviruses and Opportunistic Infections","author":"M Saag","year":"2012","unstructured":"Saag, M. et al. Cluster randomized trial of routine vs discretionary viral load monitoring among adults starting ART: Zambia. 19th Conf. Retroviruses and Opportunistic Infections (2012)."},{"key":"BFnature16046_CR63","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S1473-3099(11)70168-2","volume":"11","author":"C Laurent","year":"2011","unstructured":"Laurent, C. et al. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110\/ESTHER): a randomised non-inferiority trial. Lancet Infect. Dis. 11, 825\u2013833 (2011).","journal-title":"Lancet Infect. Dis."},{"key":"BFnature16046_CR64","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S1473-3099(13)70073-2","volume":"13","author":"S Boyer","year":"2013","unstructured":"Boyer, S. et al. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110\/ESTHER): a cost-effectiveness analysis. Lancet Infect. Dis. 13, 577\u2013586 (2013).","journal-title":"Lancet Infect. Dis."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature16046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature16046","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature16046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:47:29Z","timestamp":1684432049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature16046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":64,"journal-issue":{"issue":"7580","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["BFnature16046"],"URL":"https:\/\/doi.org\/10.1038\/nature16046","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"2 December 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests. Financial support for this publication has been provided by the Bill & Melinda Gates Foundation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}